Previous Close | 172.98 |
Open | 171.61 |
Bid | 162.61 x 900 |
Ask | 169.55 x 800 |
Day's Range | 165.56 - 172.32 |
52 Week Range | 72.18 - 189.97 |
Volume | |
Avg. Volume | 402,731 |
Market Cap | 4.768B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | 432.13 |
EPS (TTM) | 0.39 |
Earnings Date | May 06, 2024 - May 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 185.90 |
Subscribe to Yahoo Finance Plus to view Fair Value for KRYS
If you are looking for stocks that are well positioned to maintain their recent uptrend, Krystal Biotech, Inc. (KRYS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Krystal Biotech, Inc. (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Krystal Biotech, Inc. (KRYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.